Features of early pregnancy treatment in women with luteal phase defect
The purpose of this study was the first pregnancy trimester flow analysis in patients with IDLF receiving pre-gravidity training including dydrogesterone taking. Materials and methods. The drug was prescribed to 60 patients at the pregnancy planning stage. After becoming pregnant patients were divid...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Book |
| Published: |
IP Berlin A.V.,
2013-04-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The purpose of this study was the first pregnancy trimester flow analysis in patients with IDLF receiving pre-gravidity training including dydrogesterone taking. Materials and methods. The drug was prescribed to 60 patients at the pregnancy planning stage. After becoming pregnant patients were divided into two clinical groups: I - with dydrogesterone prolongation taking in trimester one (n = 36), II - dydrogesterone cessation after pregnancy verification (n = 24). The results overview. Significant differences in the incidence of adverse prenatal outcomes, with a predominance of those in clinical group II were obtained. Conclusion. Dydrogesterone discontinuation for up to 8 weeks of pregnancy, when used at the stage of preparation is irrational, as manifested not only as a threat, but the termination of pregnancy in the I trimester. |
|---|---|
| Item Description: | 2079-5696 2079-5831 |